Guided Therapeutics, Inc.
GTHP
$0.25
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.63M | -2.54M | -2.44M | -2.42M | -2.15M |
| Total Depreciation and Amortization | 103.00K | 100.00K | 97.00K | 95.00K | 93.00K |
| Total Amortization of Deferred Charges | 210.00K | 178.00K | 128.00K | 93.00K | 105.00K |
| Total Other Non-Cash Items | 422.00K | 328.00K | 84.00K | 107.00K | -68.00K |
| Change in Net Operating Assets | 786.00K | 631.00K | 783.00K | 1.00M | 898.00K |
| Cash from Operations | -1.11M | -1.31M | -1.35M | -1.12M | -1.12M |
| Capital Expenditure | -2.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.00K | -- | -- | -- | -- |
| Total Debt Issued | 823.00K | 947.00K | 792.00K | 587.00K | 387.00K |
| Total Debt Repaid | -552.00K | -510.00K | -578.00K | -477.00K | -313.00K |
| Issuance of Common Stock | 795.00K | 835.00K | 835.00K | 835.00K | 541.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -62.00K | -57.00K | -29.00K | -29.00K | -29.00K |
| Cash from Financing | 1.00M | 1.22M | 1.02M | 916.00K | 586.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -107.00K | -90.00K | -330.00K | -203.00K | -537.00K |